Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News
Greg Scott presents industry update during JPMorgan
>> View video…

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

China Pharma Wins Approval for Generic Diuretic

publication date: Jan 30, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Pharma Holdings, Inc. received SFDA approval for a generic version of Bumetanide injection, a diuretic that is given for a wide variety of indications. The company said the approval shows the SFDA has now adjusted to the new drug approval regulations implemented on October 1, 2007, and is, once again, completing new drug applications. The Bumetanide ruling bodes well for other drugs that China Pharma has submitted for approval. The company's income statement is strong, but its balance sheet has some issues. More details...

Stock Symbol: (OTCBB: CPHI)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
April 14, 2010
Guangzhou, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
Suzhou, China
June 23-24, 2010
 
Partner Events

China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners